Patent · US Active

Cytosine-based TET enzyme inhibitors

US11504369B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

President and Trustees of Bates College · US

Inventors

Andrew KENNEDY · Santa Clara, US
Gabriella N. L. Chua · San Francisco, US
Kelly L. Wassarman · Watertown, US
Haoyu Sun · Livonia, US

Key dates

Filing date	Mar 20, 2020
Grant date	Nov 22, 2022
Priority date	—
Expiry date	Mar 20, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein, in some embodiments, are cytosine analogs, compositions comprising cytosine analogs, and methods of use for inhibiting a Ten-eleven translocation (TET) enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.